F. Rauscha

发表

Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage

P. Angelberger, H. Sinzinger, I. Virgolini, 2004, European Journal of Nuclear Medicine.

Interference of programmed electromagnetic stimulation with pacemakers and automatic implantable cardioverter defibrillators.

Gernot Schmid, Günter Stix, F. Rauscha, 2006, Bioelectromagnetics.

Interferenceof Programmed Electromagnetic StimulationWith Pacemakersand Automatic Implantable Cardioverter Defibrillators

F. Rauscha, G. Schmid, J. Strametz-Juranek, 2006 .

Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction.

H. Sochor, A. Laggner, F. Rauscha, 1996, European heart journal.

Acute chest pain — identification of patients at low risk for coronary events. The impact of symptoms, medical history and risk factors

A. Laggner, F. Rauscha, M. Schillinger, 2004, Wiener Klinische Wochenschrift.

Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers

F. Rauscha, S. Graf, D. Bonderman, 2004, European journal of clinical investigation.

Acute chest pain-a stepwise approach, the challenge of the correct clinical diagnosis.

A. Laggner, F. Rauscha, M. Schillinger, 2002, Resuscitation.

In vivo quantification of cholesterol content in human carotid arteries by quantitative gamma-camera imaging after injection of autologous low density lipoproteins (LDL).

P. Angelberger, H. Sinzinger, I. Virgolini, 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.

I. Virgolini, F. Rauscha, S. Li, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.

W. Pirker, H. Sinzinger, I. Virgolini, 1993, Atherosclerosis.

Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.

H. Sinzinger, P. Fitscha, F. Rauscha, 1992, British journal of clinical pharmacology.

The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.

K. Huber, B. Binder, P. Probst, 1993, Zeitschrift fur Kardiologie.

Effect of high and low-dose aspirin on circulating endothelial cells.

H. Sinzinger, P. Fitscha, J. Kaliman, 1988, VASA. Zeitschrift fur Gefasskrankheiten.

Ticlopidine and platelet function in healthy volunteers.

A. Dembińska-kieć, H. Sinzinger, I. Virgolini, 1992, Thrombosis research.

Isradipine inhibits mitotic and proliferative activity in the arterial wall.

H. Sinzinger, P. Fitscha, F. Rauscha, 1994, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Synergistic effect of prostaglandin E1 and isosorbide dinitrate in peripheral vascular disease

J. Vane, H. Sinzinger, P. Fitscha, 1990, The Lancet.

Glucocorticoid-treatment does not influence the synthesis of thromboxane B2 and bicyclo-PGE2 in humans.

H. Sinzinger, I. Virgolini, P. Fitscha, 1989, Prostaglandins, leukotrienes, and essential fatty acids.

Comparable effect of prostaglandin E1 in decreasing in vivo platelet deposition on human lesion sites after intravenous and intraarterial application.

H. Sinzinger, P. Fitscha, J. Kaliman, 1988, Thrombosis research.

The diminished extracellular matrix production induced by isradipine, a calcium channel blocker, is completely abolished by cyclooxygenase inhibition.

H. Sinzinger, P. Fitscha, F. Rauscha, 1992, Prostaglandins, Leukotrienes and Essential Fatty Acids.

Effects of bopindolol on platelet function in hypertension at rest and during exercise.

H. Sinzinger, I. Virgolini, P. Fitscha, 1990, Prostaglandins, leukotrienes, and essential fatty acids.

Modification of platelet function by isosorbide dinitrate in patients with coronary artery disease.

H. Sinzinger, I. Virgolini, P. Fitscha, 1992, Thrombosis research.

Calcium antagonists and hypercalcaemia

H. Sinzinger, P. Fitscha, F. Rauscha, 1991, The Lancet.

Sex Differences and Long-Term Outcome in Patients With Pacemakers

C. Hengstenberg, M. Gyöngyösi, G. Laufer, 2020, Frontiers in Cardiovascular Medicine.

Compromising bradycardia: management in the emergency department.

H. Losert, A. Laggner, F. Rauscha, 2007, Resuscitation.

Evaluation of esophageal tracheal combitube in cardiopulmonary resuscitation.

M. Frass, F. Rauscha, R. Pacher, 1987, Critical care medicine.

Ventilation with the esophageal tracheal combitube in cardiopulmonary resuscitation. Promptness and effectiveness.

D. Glogar, M. Frass, F. Rauscha, 1988, Chest.

Influence of Cardiac Output on Peak t-PA Plasma Levels in Patients Receiving Thrombolytic Therapy with Recombinant Tissue-Type Plasminogen Activator – Correlation with Patency Rate

K. Huber, B. Binder, P. Probst, 1993, Thrombosis and Haemostasis.

13,14-dihydro-PGE1, an in-vivo metabolite of PGE1, decreases mitotic activity induced by corticosteroid administration.

H. Sinzinger, P. Fitscha, F. Rauscha, 1991, Eicosanoids.

Diagnostic value of onset-recordings and marker annotations in dual chamber pacemaker stored electrograms.

B. Nowak, F. Rauscha, L. Mont, 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Effects of isradipine on platelet function in hypertension at rest and during exercise.

H. Sinzinger, I. Virgolini, P. Fitscha, 1991, American journal of hypertension.

Possible risks due to exposure of workers and patients with implants by TETRA transmitters

Georg Neubauer, Wolfgang Müller, Stefan Cecil, 2014, Bioelectromagnetics.

Beneficial effect of PGI2 on circulating endothelial cells

H. Sinzinger, P. Fitscha, J. Kaliman, 1988, Basic Research in Cardiology.

Prevalence of a shortened prostacyclin half‐life in plasma in healthy adults: Results of a screening investigation

H. Sinzinger, P. Fitscha, F. Rauscha, 1990, American journal of hematology.

Isradipine improves platelet function in hypertensives

H. Sinzinger, I. Virgolini, P. Fitscha, 2004, European Journal of Clinical Pharmacology.

Platelet function and prostaglandins in patients with peripheral vascular disease treated with calcium dobesilate.

H. Sinzinger, F. Rauscha, H. Vinazzer, 1987, Prostaglandins, leukotrienes, and medicine.

Stabilization of endothelial lining and decrease in circulating endothelial cells--one mechanism underlying the clinical action of PGE1?

H. Sinzinger, I. Virgolini, P. Fitscha, 1988, British journal of clinical pharmacology.